BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37282586)

  • 1. Molecular Mechanisms of miR-214 Involved in Cancer and Drug Resistance.
    Karimi E; Dehghani A; Azari H; Zarei M; Shekari M; Mousavi P
    Curr Mol Med; 2023 May; 23(7):589-605. PubMed ID: 37282586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-106a: Promising biomarker for cancer.
    Pan YJ; Zhuang Y; Zheng JN; Pei DS
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5373-5377. PubMed ID: 27780637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and mechanism of action of microRNA-122 in cancer: Focusing on the liver.
    Al-Gazally ME; Khan R; Imran M; Ramírez-Coronel AA; Alshahrani SH; Altalbawy FMA; Turki Jalil A; Romero-Parra RM; Zabibah RS; Shahid Iqbal M; Karampoor S; Mirzaei R
    Int Immunopharmacol; 2023 Oct; 123():110713. PubMed ID: 37523968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-375: potential cancer suppressor and therapeutic drug.
    Wei J; Lu Y; Wang R; Xu X; Liu Q; He S; Pan H; Liu X; Yuan B; Ding Y; Zhang J
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34494089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-217: A regulator of human cancer.
    Zhou S; Zhu C; Pang Q; Liu HC
    Biomed Pharmacother; 2021 Jan; 133():110943. PubMed ID: 33254014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms of miR-1271 Dysregulation in Human Cancer.
    Zhou K; Cai C; Zou M; He Y; Duan S
    DNA Cell Biol; 2021 Jun; 40(6):740-747. PubMed ID: 34015233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional mechanism and clinical implications of MicroRNA-423 in human cancers.
    Ke R; Lv L; Zhang S; Zhang F; Jiang Y
    Cancer Med; 2020 Dec; 9(23):9036-9051. PubMed ID: 33174687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21: a novel therapeutic target in human cancer.
    Pan X; Wang ZX; Wang R
    Cancer Biol Ther; 2010 Dec; 10(12):1224-32. PubMed ID: 21139417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular mechanisms and therapeutic potential of microRNA-7 in cancer.
    Gu DN; Huang Q; Tian L
    Expert Opin Ther Targets; 2015 Mar; 19(3):415-26. PubMed ID: 25434362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
    Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
    J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of miRNA-216b in cancer.
    Jana S; Krishna M; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
    Cancer Lett; 2020 Aug; 484():16-28. PubMed ID: 32387443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the microRNA-302/367 cluster in cancer therapy.
    Liu J; Wang Y; Ji P; Jin X
    Cancer Sci; 2020 Apr; 111(4):1065-1075. PubMed ID: 31957939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising therapeutic role of miR-27b in tumor.
    Ding L; Ni J; Yang F; Huang L; Deng H; Wu Y; Ding X; Tang J
    Tumour Biol; 2017 Mar; 39(3):1010428317691657. PubMed ID: 28351320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of miR-760 with cancer: An overview.
    Manvati MKS; Khan J; Verma N; Dhar PK
    Gene; 2020 Jul; 747():144648. PubMed ID: 32251703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic, prognostic, and therapeutic significance of miR-139-5p in cancers.
    Khalili N; Nouri-Vaskeh M; Hasanpour Segherlou Z; Baghbanzadeh A; Halimi M; Rezaee H; Baradaran B
    Life Sci; 2020 Sep; 256():117865. PubMed ID: 32502540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic, prognostic role and molecular mechanism of miR-328 in human cancer.
    Wang Z; Xie W; Guan H
    Biomed Pharmacother; 2023 Jan; 157():114031. PubMed ID: 36413837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-221: biogenesis, function and signatures in human cancers.
    Abak A; Amini S; Sakhinia E; Abhari A
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3094-3117. PubMed ID: 29863255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.